Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-21

Clinical Trial Update: Intravenous Subdissociative-dose Ketamine Versus Morphine for Prehospital Analgesia [Phase 3]

View source ↗

Summary

Phase 3 trial comparing intravenous subdissociative-dose ketamine to morphine for prehospital analgesia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)
  • Morphine (morphine)

Snippet

Sponsor: Nantes University Hospital | Conditions: Pain Management | Phase 3 | Status: TERMINATED